REQUEST A DEMO
Total
USD $0.00
Search more companies

Vardhman Drugs Private Limited (India)

Main Activities: Health Care and Social Assistance
Full name: Vardhman Drugs Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Vardhman Drugs Private Limited is an unlisted company, incorporated on 31/05/1996. It has its registered office in the State of Uttar Pradesh, India. Company's corporate identification number (CIN) is U85110UP1996PTC020052 and registration number is 020052. The company is a trade company, it is engaged in wholesale trading.

Legal Address
101/1B Mokhampur Delhi Road Meerut Up
Meerut; Uttar Pradesh; Postal Code: 250002

Contact Details: Purchase the Vardhman Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Vardhman Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Vardhman Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Vardhman Drugs Private Limited report to view the information.
Incorporation Date:
May 31, 1996
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Vardhman Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
9.62%
Total operating revenue
20.65%
Operating profit (EBIT)
66.2%
EBITDA
31.03%
Net Profit (Loss) for the Period
43.25%
Total Assets
0.28%
Total Equity
-11.11%
Operating Profit Margin (ROS)
4.06%
Net Profit Margin
1.79%
Return on Equity (ROE)
7.08%
Debt/Equity
96.65%
Quick Ratio
0.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?